A detailed history of Mml Investors Services, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Mml Investors Services, LLC holds 48,077 shares of VRTX stock, worth $19.6 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
48,077
Previous 37,640 27.73%
Holding current value
$19.6 Million
Previous $17.6 Million 26.74%
% of portfolio
0.08%
Previous 0.07%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$460.0 - $505.78 $4.8 Million - $5.28 Million
10,437 Added 27.73%
48,077 $22.4 Million
Q2 2024

Aug 14, 2024

SELL
$392.81 - $485.53 $1.52 Million - $1.88 Million
-3,875 Reduced 9.33%
37,640 $17.6 Million
Q1 2024

May 14, 2024

BUY
$407.69 - $446.08 $953,179 - $1.04 Million
2,338 Added 5.97%
41,515 $17.4 Million
Q4 2023

Feb 14, 2024

BUY
$343.0 - $410.68 $2.12 Million - $2.54 Million
6,186 Added 18.75%
39,177 $15.9 Million
Q3 2023

Nov 14, 2023

BUY
$338.18 - $362.46 $2.73 Million - $2.92 Million
8,059 Added 32.32%
32,991 $11.5 Million
Q2 2023

Aug 14, 2023

BUY
$314.42 - $351.91 $1.33 Million - $1.49 Million
4,229 Added 20.43%
24,932 $8.77 Million
Q1 2023

May 12, 2023

SELL
$283.23 - $323.1 $881,694 - $1.01 Million
-3,113 Reduced 13.07%
20,703 $6.52 Million
Q4 2022

Feb 13, 2023

BUY
$285.76 - $321.48 $697,540 - $784,732
2,441 Added 11.42%
23,816 $6.88 Million
Q3 2022

Nov 14, 2022

BUY
$273.83 - $305.53 $109,532 - $122,211
400 Added 1.91%
21,375 $6.19 Million
Q2 2022

Aug 12, 2022

BUY
$234.96 - $292.55 $535,708 - $667,014
2,280 Added 12.2%
20,975 $5.91 Million
Q1 2022

May 13, 2022

BUY
$221.42 - $260.97 $1.29 Million - $1.52 Million
5,833 Added 45.35%
18,695 $4.88 Million
Q4 2021

Feb 14, 2022

BUY
$177.01 - $223.45 $306,050 - $386,345
1,729 Added 15.53%
12,862 $2.82 Million
Q3 2021

Nov 15, 2021

BUY
$181.39 - $202.99 $25,938 - $29,027
143 Added 1.3%
11,133 $2.02 Million
Q2 2021

Aug 13, 2021

SELL
$187.49 - $221.1 $1.18 Million - $1.39 Million
-6,282 Reduced 36.37%
10,990 $2.22 Million
Q1 2021

May 14, 2021

BUY
$207.02 - $241.31 $285,894 - $333,249
1,381 Added 8.69%
17,272 $3.71 Million
Q4 2020

Feb 12, 2021

BUY
$207.01 - $276.09 $538,847 - $718,662
2,603 Added 19.59%
15,891 $3.76 Million
Q3 2020

Nov 13, 2020

SELL
$255.65 - $303.1 $95,613 - $113,359
-374 Reduced 2.74%
13,288 $3.62 Million
Q2 2020

Aug 14, 2020

BUY
$225.48 - $295.8 $1.57 Million - $2.05 Million
6,947 Added 103.45%
13,662 $3.97 Million
Q1 2020

May 14, 2020

BUY
$199.77 - $247.81 $270,089 - $335,039
1,352 Added 25.21%
6,715 $1.6 Million
Q4 2019

Feb 11, 2020

BUY
$166.71 - $223.91 $195,050 - $261,974
1,170 Added 27.9%
5,363 $1.17 Million
Q3 2019

Nov 14, 2019

SELL
$166.23 - $187.09 $114,532 - $128,905
-689 Reduced 14.11%
4,193 $710,000
Q2 2019

Aug 13, 2019

BUY
$164.61 - $190.37 $140,247 - $162,195
852 Added 21.14%
4,882 $895,000
Q1 2019

May 10, 2019

BUY
$163.73 - $194.7 $76,789 - $91,314
469 Added 13.17%
4,030 $741,000
Q4 2018

Feb 14, 2019

SELL
$151.91 - $192.21 $31,293 - $39,595
-206 Reduced 5.47%
3,561 $590,000
Q3 2018

Nov 07, 2018

BUY
$167.73 - $192.74 $197,753 - $227,240
1,179 Added 45.56%
3,767 $726,000
Q2 2018

Aug 13, 2018

BUY
$145.72 - $169.96 $41,967 - $48,948
288 Added 12.52%
2,588 $440,000
Q1 2018

May 11, 2018

SELL
$151.6 - $177.13 $16,524 - $19,307
-109 Reduced 4.52%
2,300 $375,000
Q4 2017

Feb 13, 2018

SELL
$137.28 - $155.55 $228,433 - $258,835
-1,664 Reduced 40.85%
2,409 $361,000
Q3 2017

Nov 14, 2017

BUY
$148.13 - $162.24 $603,333 - $660,803
4,073
4,073 $619,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Mml Investors Services, LLC Portfolio

Follow Mml Investors Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mml Investors Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mml Investors Services, LLC with notifications on news.